EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Hayley R Lau, Hayley S Smith, Begüm Alural, Claire E Martin, Laura A New, Manali Tilak, Sara L Banerjee, Hannah N Robeson, Nicolas Bisson, Anne-Claude Gingras, Jasmin Lalonde, Nina Jones iD

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.70022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Hayley R Lau und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, University of Guelph, Canada. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, ErbB Receptors, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Cancer Research, Cancer Research Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple‐negative breast cancer (TNBC) is highly metastatic and presents clinical challenges given the lack of targeted therapies. Here, we report that the ShcD phosphotyrosine adaptor protein is upregulated in TNBC, and its expression correlates with overall reduced patient survival and decreased response to chemotherapy. In human breast cancer cells, we demonstrate that ShcD expression promotes cell invasion and reduces adhesion, and that these effects are abrogated by mutating the ShcD phosphotyrosine binding (PTB) domain. Similarly, in a three‐dimensional assembloid model, ShcD‐expressing spheroids derived from brain metastatic TNBC cells show enhanced infiltration into cerebral organoids. Using a proteomic screen for ShcD binding partners, we identify multiple components of epidermal growth factor receptor (EGFR) signaling and confirm these interactions with ShcD but not the PTB mutant. Interestingly, the ShcD interactome correlates with EGFR tyrosine kinase inhibitor resistance, in line with our findings that ShcD overexpression results in hyperphosphorylation of EGFR while ShcD knockout or PTB mutation reverts this response. Lastly, pharmacological inhibition of the ShcD PTB domain using indomethacin in TNBC cells decreases EGFR binding and hyperphosphorylation and reduces cell invasion. Altogether, our results identify ShcD as a potential contributor to metastasis in TNBC, and they provide a molecular basis for clinical targeting of adaptor proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsErbB ReceptorsSignal TransductionHumansCell Line, TumorNeoplasm InvasivenessFemalePhosphorylation

Stichwörter der Autor:innen

EGFRShcD/Shc4breast cancercell signalinginvasion

Substanzen

ErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biology, University of Guelph, Canada.
  • Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.
  • Cancer Research Centre, Quebec Network for Research on Protein Function, Engineering, and Applications (PROTEO) and Centre Hospitalier Universitaire de Québec Research Centre-Université Laval, Québec City, Canada.

ORCID-Profile: Nina Jones

Förderung

  • Institute of Cancer Research
  • Cancer Research Society

Zitieren

APA

Lau, H. R., Smith, H. S., Alural, B., Martin, C. E., New, L. A., Tilak, M., Banerjee, S. L., Robeson, H. N., Bisson, N., Gingras, A. C., Lalonde, J., & Jones, N. (2025). ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling. Molecular Oncology. https://doi.org/10.1002/1878-0261.70022

Vancouver

Lau HR, Smith HS, Alural B, Martin CE, New LA, Tilak M, et al. ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling. Molecular Oncology. 2025. doi:10.1002/1878-0261.70022

BibTeX
@article{Lau2025,
  author = {Lau, Hayley R and Smith, Hayley S and Alural, Begüm and Martin, Claire E and New, Laura A and Tilak, Manali and Banerjee, Sara L and Robeson, Hannah N and Bisson, Nicolas and Gingras, Anne-Claude and Lalonde, Jasmin and Jones, Nina},
  title = {ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.70022}
}
Kostenlos starten →